<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Polycomb-group (PcG) proteins, such as BMI-1 and EZH2, form multimeric gene-repressing complexes involved in axial patterning, hematopoiesis, and cell cycle regulation </plain></SENT>
<SENT sid="1" pm="."><plain>In addition, BMI-1 is involved in experimental <z:e sem="disease" ids="C0598766" disease_type="Neoplastic Process" abbrv="">lymphomagenesis</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>Little is known about its role in human <z:e sem="disease" ids="C0598766" disease_type="Neoplastic Process" abbrv="">lymphomagenesis</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>Here, BMI-1 and EZH2 expression patterns are analyzed in a variety of B-cell non-Hodgkin <z:hpo ids='HP_0002665'>lymphomas</z:hpo> (B-NHLs), including small lymphocytic <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, large B-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, mantle-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, and Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>In contrast to the mutually exclusive pattern of BMI-1 and EZH2 in reactive follicles, the neoplastic cells in B-NHLs of intermediate- and high-grade <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e> showed strong coexpression of BMI-1 and EZH2 </plain></SENT>
<SENT sid="5" pm="."><plain>This pattern overlapped with the expression of Mib-1/Ki-67, a marker for proliferation </plain></SENT>
<SENT sid="6" pm="."><plain>Neoplastic cells in B-NHL of low-grade <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e> were either BMI-1(low)/EZH2(+) (neoplastic centroblasts) or BMI-1(low)EZH2(-) (neoplastic centrocytes) </plain></SENT>
<SENT sid="7" pm="."><plain>These observations show that low-, intermediate-, and high grade B-NHLs are associated with increased coexpression of the BMI-1 and EZH2 PcG proteins, whose <z:mpath ids='MPATH_458'>normal</z:mpath> expression pattern is mutually exclusive </plain></SENT>
<SENT sid="8" pm="."><plain>This expression pattern is probably caused by a failure to down-regulate BMI-1 in dividing neoplastic cells, because BMI-1 expression is absent from <z:mpath ids='MPATH_458'>normal</z:mpath> dividing B cells </plain></SENT>
<SENT sid="9" pm="."><plain>These observations are in agreement with findings in studies of Bmi-1 transgenic mice </plain></SENT>
<SENT sid="10" pm="."><plain>The extent of BMI-1/EZH2 coexpression correlated with clinical grade and the presence of Mib-1/Ki-67 expression, suggesting that the irregular expression of BMI-1 and EZH2 is an early event in the formation of B-NHL </plain></SENT>
<SENT sid="11" pm="."><plain>This points to a role for abnormal PcG expression in human <z:e sem="disease" ids="C0598766" disease_type="Neoplastic Process" abbrv="">lymphomagenesis</z:e> </plain></SENT>
<SENT sid="12" pm="."><plain>(Blood </plain></SENT>
<SENT sid="13" pm="."><plain>2001;97:3896-3901) </plain></SENT>
</text></document>